The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study
Open accessThe DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Abstract
Glutamatergic excitotoxicity is hypothesised to underlie synaptic loss in schizophrenia pathogenesis, but it is unknown whether synaptic markers are related to glutamatergic function in vivo. Additionally, it has been proposed that N-acetyl aspartate (NAA) levels reflect neuronal integrity. Here, we investigated whether synaptic vesicle glycoprotein 2 A (SV2A) levels are related to glutamatergic markers and NAA in healthy volunteers (HV) and schizophrenia patients (SCZ). Forty volunteers (SCZ n = 18, HV n = 22) underwent [11 C]UCB-J positron emission tomography and proton magnetic resonance spectroscopy (1 H-MRS) imaging in the left hippocampus and anterior cingulate cortex (ACC) to index [11 C]UCB-J distribution volume ratio (DVR), and creatine-scaled glutamate (Glu/Cr), glutamate and glutamine (Glx/Cr) and NAA (NAA/Cr). In healthy volunteers, but not patients, [11 C]UCB-J DVR was significantly positively correlated with Glu/Cr, in both the hippocampus and ACC. Furthermore, in healthy volunteers, but not patients, [11 C]UCB-J DVR was significantly positively correlated with Glx/Cr, in both the hippocampus and ACC. There were no significant relationships between [11 C]UCB-J DVR and NAA/Cr in the hippocampus or ACC in healthy volunteers or patients. Therefore, an appreciable proportion of the brain 1 H-MRS glutamatergic signal is related to synaptic density in healthy volunteers. This relationship is not seen in schizophrenia, which, taken with lower synaptic marker levels, is consistent with lower levels of glutamatergic terminals and/or a lower proportion of glutamatergic relative to GABAergic terminals in the ACC in schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1 Synaptic density and glutamate in healthy volunteers. Significant positive relationship between [11C]UCB-J distribution volume ratio and Glu/Cr levels in the ACC in the healthy volunteer (HV) group. ACC = anterior cingulate cortex.](https://figures.cochat.ai/paper-figures/2110cab1744340c6972a693c1bca1444/the-relationship-between-synaptic-density-marker-sv2a-glutamate-and-n-acetyl-figure-1.jpg)
![Fig. 2 Synaptic density and glutamate in patients with schizophrenia. No significant relationship between [11C]UCB-J distribution volume ratio and Glu/Cr levels in the ACC in the schizophrenia (SCZ) group. ACC = anterior cingulate cortex.](https://figures.cochat.ai/paper-figures/a2ba344c9ae941fd963fdf773d4cadff/the-relationship-between-synaptic-density-marker-sv2a-glutamate-and-n-acetyl-figure-2.jpg)
![Fig. 3 Synaptic density and glutamate in healthy volunteers. Significant positive relationship between [11C]UCB-J distribution volume ratio and Glu/Cr levels in the left hippocampus in the healthy volunteer (HV) group.](https://figures.cochat.ai/paper-figures/326abe116929481bbf48bb47e2d7d24a/the-relationship-between-synaptic-density-marker-sv2a-glutamate-and-n-acetyl-figure-3.jpg)
![Fig. 4 Synaptic density and glutamate in patients with schizophrenia. No significant relationship between [11C]UCB-J distribution volume ratio and Glu/Cr levels in the left hippocampus in the schizophrenia (SCZ) group.](https://figures.cochat.ai/paper-figures/bd011a2e5c4148d899c4b0c8720dcccc/the-relationship-between-synaptic-density-marker-sv2a-glutamate-and-n-acetyl-figure-4.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“[173], schizophrenia [174, 175], post-traumatic stress disorder [132], stroke [176], cocaine use disorder [133], and cannabis use disorder [177], as well as in normal aging [178].”
From Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression (2025) · cites this paper as [174]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Crivello, F., Etard, O., Delcroix, N., Mazoyer, B., & Joliot, M. (2002) · NeuroImage · doi:10.1006/nimg.2001.0978 · Cited by 16,319
Danbolt, N. C. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00067-8 · Cited by 4,227
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
Insel, T. R. (2010) · Nature · doi:10.1038/nature09552 · Cited by 1,783
Glutamate receptor dysfunction and schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685
Decreased Dendritic Spine Density on Prefrontal Cortical Pyramidal Neurons in Schizophrenia
Glantz, L. A., & Lewis, D. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.1.65 · Cited by 1,636
Automatic quantitation of localized in vivo1H spectra with LCModel
Provencher, S. W. (2001) · NMR in Biomedicine · doi:10.1002/nbm.698 · Cited by 1,634
De novo mutations in schizophrenia implicate synaptic networks
Fromer, M., Pocklington, A. J., Kavanagh, D. H., Williams, H. J., Dwyer, S., Gormley, P., Georgieva, L., Rees, E., Palta, P., Ruderfer, D. M., et al. (2014) · Nature · doi:10.1038/nature12929 · Cited by 1,617
McCutcheon, R. A., Reis Marques, T., & Howes, O. D. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.3360 · Cited by 1,481
Self-citation
Cited by
Howes, O. D., & Shatalina, E. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.06.017 · Cited by 256
Self-citationThe synaptic hypothesis of schizophrenia version III: a master mechanism
Howes, O. D., & Onwordi, E. C. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02043-w · Cited by 234
Self-citationSchizophrenia: from neurochemistry to circuits, symptoms and treatments
Howes, O. D., Bukala, B. R., & Beck, K. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-023-00904-0 · Cited by 192
Self-citationNeuroimaging in schizophrenia: an overview of findings and their implications for synaptic changes
Howes, O. D., Cummings, C., Chapman, G. E., & Shatalina, E. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01426-x · Cited by 170
Self-citationSynaptic Vesicle Glycoprotein 2A: Features and Functions
Rossi, R., Arjmand, S., Bærentzen, S. L., Gjedde, A., & Landau, A. M. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.864514 · Cited by 123
“Interestingly, no significant relationship was reported between [11C]UCBJ binding and glutamate levels in the patients, while a positive correlation was detected in healthy control subjects (Onwordi et al., 2021).”
Background
Metadata
- Authors
- Onwordi, E. C., Whitehurst, T., Mansur, A., Statton, B., Berry, A., Quinlan, M., O’Regan, D. P., Rogdaki, M., Marques, T. R., Rabiner, E. A., Gunn, R. N., Vernon, A. C., Natesan, S., & Howes, O. D.
- Affiliations
- King's College London (GB)
- Hammersmith Hospital (GB)
- Corresponding author
- Onwordi, Ellis Chika
- ORCID
- Venue
- Translational Psychiatry
- Published
- 2021-07-17
- Volume
- 11
- Issue
- 1
- Pages
- 393-393
- ISSN
- 2158-3188 (ISSN-L)
- PMC
- PMC8290006
- OpenAlex
- W3183696218
- Cited by
- 55
- References
- 96
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 14 · 2023: 9 · 2022: 14 · 2021: 1
- FWCI
- 6.81
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Translational Psychiatry (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Spiral (Imperial College London) (submittedVersion, other-oa)
- Funders
- South London and Maudsley NHS Foundation Trust
- Wellcome Trust (094849, 094849/Z/10/Z)
- National Institute for Health and Care Research
- British Heart Foundation (NH/17/1/32725)
- King's College London
- Medical Research Council (MC- A656-5QD30, MR/L022176/1, 094849/Z/10/Z, MR/N026063/1, MR/N027078/1)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Keywords
- schizophrenia, synaptic density, SV2A, glutamate, N-acetylaspartate, glutamate excitotoxicity, [11C]UCB-J, glutamate/glutamine, hippocampus, anterior cingulate cortex, glutamatergic terminals, GABAergic terminals, synaptic loss
- MeSH terms
- Aspartic Acid, Brain, Creatine, Humans, Membrane Glycoproteins, Nerve Tissue Proteins, Schizophrenia, Glutamic Acid, Positron-Emission Tomography, Neuroimaging, Healthy Volunteers, Proton Magnetic Resonance Spectroscopy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study. https://app.cochat.ai/papers/10.1038/s41398-021-01515-3
- The paper
- Onwordi, E. C., Whitehurst, T., Mansur, A., Statton, B., Berry, A., Quinlan, M., O’Regan, D. P., Rogdaki, M., Marques, T. R., Rabiner, E. A., Gunn, R. N., Vernon, A. C., Natesan, S., & Howes, O. D. (2021). The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study. Translational Psychiatry. https://doi.org/10.1038/s41398-021-01515-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.